Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GenSight appoints new COO

This article was originally published in Scrip

Executive Summary

Paris, France-based GenSight Biologics, which develops gene-based therapies to preserve or restore vision in people with degenerative retinal and inherited ophthalmologic diseases, has named Dr Jean-Philippe Combal chief operating officer. Dr Combal will lead the company's operational activities and the development of its products. Prior to joining GenSight, he was leading development of early stage dermatological products – up to Phase IIb – at Galderma International.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC025237

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel